移遠通信(603236.SH):子公司擬斥2000萬元參設股權投資基金
格隆匯 9 月 7日丨移遠通信(603236.SH)公佈,為符合公司發展規劃,促進公司在物聯網行業的戰略佈局,公司全資子公司合肥移瑞於2020年9月7日簽署了《菏澤喬貝京瑞創業投資合夥企業(有限合夥)合夥協議》,合肥移瑞作為有限合夥人擬出資2000萬元人民幣,與其他11名合夥人共同投資設立菏澤喬貝京瑞創業投資合夥企業(有限合夥)(暫定名,最終名稱以工商部門核准為準)。
公司此次對外投資是在保證公司及子公司主營業務正常發展的前提下作出的投資決策,不會對公司及子公司現有業務開展造成資金壓力,不會影響公司及子公司生產經營活動的正常運行,不存在損害上市公司及全體股東利益的情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.